Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/27574
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThemis, M-
dc.contributor.authorAl-Haque, S-
dc.contributor.authorWang, W-
dc.contributor.authorStrobel-Freidekind, O-
dc.contributor.authorDeichmann, A-
dc.contributor.authorHenkaerts, E-
dc.contributor.authorTakeuchi, Y-
dc.contributor.authorWeise, F-
dc.contributor.authorSuleman, S-
dc.contributor.authorFawaz, S-
dc.contributor.authorGil-Farina, I-
dc.contributor.authorSchmidt, M-
dc.date.accessioned2023-11-07T17:12:39Z-
dc.date.available2023-11-07T17:12:39Z-
dc.date.issued2021-10-01-
dc.identifierORCID iD: Michael Themis https://orcid.org/0000-0002-6719-4271-
dc.identifierORCID iD: Saqlain Suleman https://orcid.org/0000-0003-4610-9397-
dc.identifier.citationThemis, M. et al. (2021) 'Application of InGetox to assess the genotoxicity of LV and AAV vectors', Human Gene Therapy, 32 (19-20), pp. A136 - A136. doi: 10.1089/hum.2021.29180.abstracts.en_US
dc.identifier.issn1043-0342-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/27574-
dc.descriptionPoster Presentation PXXX, presented at the ESGCT 28th Annual Congress In collaboration with BSGCT Virtual Conference, October 19–22, 2021.-
dc.description.abstract...en_US
dc.format.extentA136 - A136-
dc.format.mediumPrint-Electronic-
dc.language.isoen_USen_US
dc.publisherMary Ann Lieberten_US
dc.rightsCopyright © 2021 Mary Ann Liebert, Inc., publishers. This is the accepted version of the following article: Themis, M. et al. (2021) 'Application of InGetox to assess the genotoxicity of LV and AAV vectors', ESGCT Collaborative Virtual Congress, Virtual, October 19–22, 202q, pp. A136-A136, which has now been formally published in final form at Human Gene Therapy, 32 (19-20) at https://www.liebertpub.com/doi/full/10.1089/hum.2021.29180.abstracts. This original submission version of the article may be used for non-commercial purposes in accordance with the Mary Ann Liebert, Inc., publishers’ self-archiving terms and conditions, see: https://home.liebertpub.com/authors/writing-guidelines/151.-
dc.rights.urihttps://home.liebertpub.com/authors/writing-guidelines/151-
dc.titleApplication of InGetox to assess the genotoxicity of LV and AAV vectorsen_US
dc.typeConference Paperen_US
dc.relation.isPartOfHuman Gene Therapy-
pubs.issue19-20-
pubs.publication-statusPublished-
pubs.volume32-
dc.identifier.eissn1557-7422-
dc.rights.holderMary Ann Liebert, Inc.-
Appears in Collections:Dept of Life Sciences Embargoed Research Papers

Files in This Item:
File Description SizeFormat 
ASGCT2020_InGeToxTalk_01May2020.pdfEmbargoed indefinitely3.69 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.